Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination of metformin and p38 MAPK inhibitor, SB203580, reduced myocardial ischemia/reperfusion injury in non-obese type 2 diabetic Goto-Kakizaki rats.
Sanit J, Prompunt E, Adulyaritthikul P, Nokkaew N, Mongkolpathumrat P, Kongpol K, Kijtawornrat A, Petchdee S, Barrère-Lemaire S, Kumphune S. Sanit J, et al. Among authors: kumphune s. Exp Ther Med. 2019 Sep;18(3):1701-1714. doi: 10.3892/etm.2019.7763. Epub 2019 Jul 10. Exp Ther Med. 2019. PMID: 31410128 Free PMC article.
PPARβ/δ Is Required for Mesenchymal Stem Cell Cardioprotective Effects Independently of Their Anti-inflammatory Properties in Myocardial Ischemia-Reperfusion Injury.
Nernpermpisooth N, Sarre C, Barrere C, Contreras R, Luz-Crawford P, Tejedor G, Vincent A, Piot C, Kumphune S, Nargeot J, Jorgensen C, Barrère-Lemaire S, Djouad F. Nernpermpisooth N, et al. Among authors: kumphune s. Front Cardiovasc Med. 2021 Sep 20;8:681002. doi: 10.3389/fcvm.2021.681002. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34616778 Free PMC article.
PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia-reperfusion injury.
Sarre C, Contreras-Lopez R, Nernpermpisooth N, Barrere C, Bahraoui S, Terraza C, Tejedor G, Vincent A, Luz-Crawford P, Kongpol K, Kumphune S, Piot C, Nargeot J, Jorgensen C, Djouad F, Barrere-Lemaire S. Sarre C, et al. Among authors: kumphune s. Stem Cell Res Ther. 2022 Apr 23;13(1):167. doi: 10.1186/s13287-022-02840-0. Stem Cell Res Ther. 2022. PMID: 35461240 Free PMC article.
Correction: PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia-reperfusion injury.
Sarre C, Contreras-Lopez R, Nernpermpisooth N, Barrere C, Bahraoui S, Terraza C, Tejedor G, Vincent A, Luz-Crawford P, Kongpol K, Kumphune S, Piot C, Nargeot J, Jorgensen C, Djouad F, Barrere-Lemaire S. Sarre C, et al. Among authors: kumphune s. Stem Cell Res Ther. 2022 Jul 26;13(1):338. doi: 10.1186/s13287-022-03086-6. Stem Cell Res Ther. 2022. PMID: 35883123 Free PMC article. No abstract available.
Adeno-associated virus 9 vector-mediated cardiac-selective expression of human secretory leukocyte protease inhibitor attenuates myocardial ischemia/reperfusion injury.
Mongkolpathumrat P, Nernpermpisooth N, Kijtawornrat A, Pikwong F, Chouyratchakarn W, Yodsheewan R, Unajak S, Kumphune S. Mongkolpathumrat P, et al. Among authors: kumphune s. Front Cardiovasc Med. 2022 Aug 19;9:976083. doi: 10.3389/fcvm.2022.976083. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36061560 Free PMC article.
Heart rate reduction after genetic ablation of L-type Cav1.3 channels induces cardioprotection against ischemia-reperfusion injury.
Delgado-Betancourt V, Chinda K, Mesirca P, Barrère C, Covinhes A, Gallot L, Vincent A, Bidaud I, Kumphune S, Nargeot J, Piot C, Wickman K, Mangoni ME, Barrère-Lemaire S. Delgado-Betancourt V, et al. Among authors: kumphune s. Front Cardiovasc Med. 2023 Aug 1;10:1134503. doi: 10.3389/fcvm.2023.1134503. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37593151 Free PMC article.
47 results